Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

178 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-22

Study Completion Date

2024-12-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Healthcare providers (HCP) serving the El Paso U.S.-Mexico Border Region will be recruited to compare educational and professional skills interventions focused on the human papillomavirus (HPV). Our hypothesis is that improving provider knowledge and communication strategies about HPV and its vaccine will reduce hesitancy and increase uptake and completion among the populations they serve.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Culturally Tailored HPV Psychoeducational Multimedia Intervention

NCT06098690

Health Knowledge, Attitudes, Practice Vaccine-Preventable Diseases Intention +1 more

RECRUITING NA

ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention

NCT06535139

Papillomavirus Vaccines

RECRUITING NA

An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among Women

NCT02464358

Human Papillomavirus Infection

COMPLETED NA

Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake

NCT03337269

HPV-Related Cervical Carcinoma

COMPLETED NA

Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination Intervention

NCT05524480

Cancer Prevention

ENROLLING_BY_INVITATION NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A sample of emerging \[in training\] and current \[in practice\] health professionals from the El Paso U.S.-Mexico Border Region will be recruited to participate in a human papillomavirus (HPV) educational and professional skills intervention. Hypothesis: improving provider knowledge and communication strategies about HPV and its vaccine will reduce hesitancy and increase uptake and completion among eligible individuals through a tailored multi-media intervention to strengthen providers' ability to discuss HPV and vaccination in an informed and culturally competent manner, and increase subsequent provider recommendations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Personnel Attitude Health Knowledge, Attitudes, Practice

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A parallel trial design will be used to examine the effectiveness of a tailored HPV education and professional skills intervention. Emerging and current healthcare providers will be randomly assigned to one of two conditions: 1) treatment condition in which they will receive a tailored Education and Professional Skills Intervention, and 2) control condition in which they will receive general, publicly available information about HPV and communication skills. Participants will then be followed over time and the responses will be compared between groups.

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Outcome Assessors

* Participants \[blinding\]: participants will be randomly assigned to treatment and control groups, they will not be made aware of other participant's receipt of treatment or control materials. Participants will be asked not to discuss this project outside of the intervention; delivery of the intervention or other educational materials will be virtual, limiting the ability of participants to interact with one another during the study.
* Outcome assessor \[blinding\]: to reduce bias in the implementation and assessment of the clinical trial, participant information and pre-post survey responses will be maintained separately from the assignment and delivery of the intervention.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment

A tailored HPV education and professional skills intervention.

Group Type EXPERIMENTAL

Tailored HPV Education and Professional Skills Intervention Group

Intervention Type BEHAVIORAL

The provider education and professional skills intervention will involve audio and visual content and will be delivered in the English language.

Control

General/publicly available educational materials on HPV and communication skills.

Group Type ACTIVE_COMPARATOR

General HPV Education and Communication Skills Control Group

Intervention Type BEHAVIORAL

The general provider education intervention will involve audio and visual content and will be delivered in the English language.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tailored HPV Education and Professional Skills Intervention Group

The provider education and professional skills intervention will involve audio and visual content and will be delivered in the English language.

Intervention Type BEHAVIORAL

General HPV Education and Communication Skills Control Group

The general provider education intervention will involve audio and visual content and will be delivered in the English language.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Current (in practice) or emerging (in training - medical student, resident, or fellow) healthcare provider
* Working/training or living in the El Paso U.S.-Mexico Border Region (i.e., El Paso County, TX-Southern New Mexico)
* Have the authorization to recommend/prescribe/administer the HPV vaccine

Exclusion Criteria

* Unaffiliated with the El Paso U.S.-Mexico Border Region (i.e., El Paso County, TX-Southern New Mexico)
* Participation in Phases I or II of the larger research project \[cross-sectional phases\]
* Does not identify as a current or emerging healthcare provider
* Declines or is unable to participate in the full intervention and follow-up time-points
* Unable to complete participation and activities in the English language

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes